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Background: Decisions about how to treat patients with acute exacerbations of
obstructive airways disease—chronic obstructive pulmonary disease (COPD), asthma or
mixed diagnoses—often require an understanding of prognosis. This depends on the
severity of the acute deterioration and the patient’s functional reserve. There are
currently no validated disease-specific scores that measure the severity of the acute
exacerbation.
Objective: To develop an acute physiology score for exacerbations of obstructive airways
disease.
Design: Secondary analysis of a high-quality clinical database, the Case Mix Programme
Database.
Setting: One hundred and sixty-eight adult, general critical care units in England, Wales
and Northern Ireland.
Results: A total of 8527 patients with obstructive airways disease were identified with a
mean (SD) age of 65.9 (9.7) years and hospital mortality of 35.5%. The COPD and Asthma
Physiology Score (CAPS) was developed using logistic regression. The CAPS included eight
variables: heart rate, mean arterial blood pressure, pH, sodium, urea, creatinine, albumin
and white blood cell count. The score had fair discrimination with an area under the
receiver operating characteristic curve of 0.718. This performance was reproduced in a
further validation dataset of 7957 patients. The discrimination of the CAPS in these
validation data exceeded that of the acute physiology scores from APACHE II and III and the
physiological components of SAPS II.Elsevier Ltd. All rights reserved.
7388 2856; fax: +44 20 7388 3759.
arc.org (D.A. Harrison).
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COPD and Asthma Physiology Score 1995Conclusion: The CAPS can be used to estimate the prognostic impact of physiological
derangements accompanying an acute exacerbation of obstructive airways disease and has
the potential for even greater predictive performance when combined with measures of a
patient’s functional reserve.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Exacerbations of chronic obstructive pulmonary disease
(COPD) are responsible for a substantial proportion of
emergency medical admissions to hospital; by 2020, COPD
is expected to become the third leading cause of death in
the world.1 The management of acute respiratory failure in
COPD involves decisions about ventilatory support and an
understanding of the patient’s prognosis can be helpful in
guiding such decisions. Clinicians can find such prognostica-
tion difficult2 and prognostic models may have a role in
supporting decision-making.
To date the US Study to Understand Prognoses and
Preferences for Outcomes and Risks of Treatments (SUP-
PORT) has been the only adequately powered prospective
study that has produced a predictive model for the prognosis
of acutely ill COPD patients. It was better calibrated than
clinicians in predicting mortality.3 In common with outcome
prediction models such as the Acute Physiology, Age and
Chronic Health Evaluation (APACHE) III model,4 the SUPPORT
model contains a measure of function in the period of
stability pre-exacerbation and a measure of the severity of
the acute illness in terms of acute physiological measures.
The weighting of risk factors in prognostic models requires
at least 10 deaths per variable in order to avoid over fitting5
and where variables are categorised into n levels, 10 deaths
will be required for each of n1 levels. For example,
albumin categorised into three levels ofo29.9 g l–1,
30–34.9 g l–1 and 4 35 g l–1 would require 20 deaths. Even
with a sample size of 1016 patients SUPPORT did not have
the power to develop a COPD specific acute physiology score
and instead used the acute physiology score from APACHE III.
However the SUPPORT workers found that giving additional
weight to two factors already weighted in the acute
physiology score from APACHE III—albumin and the PaO2/
FiO2 ratio—added additional explanatory power to the
SUPPORT model, suggesting that disease-specific acute
physiology scores are likely to be more useful than generic
scores.
The transfer of prediction models between healthcare
systems is problematic6 and we therefore set out to produce
a COPD outcome model to help physicians make decisions for
COPD patients admitted to UK hospitals as emergencies (the
COPD and Asthma Outcome Study or CAOS model). In the
light of the lessons from SUPPORTwe aimed to include in this
model a disease specific acute physiology score developed
using patients with obstructive airways disease admitted to
UK intensive care units (ICUs). This paper describes the
development of the COPD and Asthma Physiology Score
(CAPS), which was designed to take account of the severity
of the patient’s current exacerbation for use alongsidemeasures of the patient’s functional reserve. In particular, it
was intended for use prior to admission to critical care using
physiological data that would be readily available and
reliably measurable outside critical care areas.
As the explicit aim of the study was to use a large UK
database to develop a model for acute physiology, no
attempt was made to include variables that reflect func-
tional reserve. Factors that reflect functional reserve,
such as age and exercise tolerance, would be collected
prospectively in the smaller CAOS study. The CAOS study
and the development of the CAOS model is reported in
detail elsewhere.7 Briefly, it was a prospective observat-
ional cohort study that recruited patients over the age of 45
years admitted to intensive care with exacerbations
of obstructive airways disease from 95 hospitals in England,
Wales and Northern Ireland. Data were collected on
patients’ characteristics prior to ICU admission and used to
develop an outcome model to predict 180-day mortality.
Methods
Case Mix Programme Database
Data were extracted for 276,731 admissions to 168 adult,
general critical care units—ICUs and combined intensive
care/high dependency units—participating in the Case Mix
Programme, the national comparative audit of critical care
in England, Wales and Northern Ireland. The data underwent
extensive validation, both locally and centrally, before
inclusion in the Case Mix Programme Database. Further
details of the data collection and validation process have
been published previously.8 The Case Mix Programme
obtained Section 60 approval under the Health and Social
Care Act 2001 in August 2005.
Selection of cases
Primary and secondary reasons for admission to the critical
care unit are recorded in the Case Mix Programme using a
specially derived hierarchical approach, the ICNARC Coding
Method.9 Cases were extracted from the Case Mix Pro-
gramme Database if they were at least 45 years old on
admission to the critical care unit and met either of the
following two conditions:1. The primary reason for admission was any of: chronic
obstructive airways disease (COAD/COPD); exacer-
bation of chronic obstructive airways disease (COAD/
COPD); emphysema; asthma attack in new or known
asthmatic; or
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above four conditions, and the primary reason
for admission was any of: bacterial pneumonia; fungal
or yeast pneumonia; viral pneumonia; parasitic pneumo-
nia; pneumonia, no organism isolated; left ventricular
failure; right ventricular failure; bi-ventricular failure;
cor pulmonale; acute bronchitis or laryngotracheobron-
chitis; sputum retention; lung collapse or atelectasis;
lung collapse due to pneumothorax; lung collapse
secondary to broncho-pleural fistula; pleurisy; fractured
ribs.
The diagnostic codes included all those that clinicians
would use for patients considered to have exacerbations of
obstructive airways disease. In older smokers in the acute
setting it can be difficult to distinguish between patients
with pure asthma from those with chronic obstructive
airways disease and it was for this reason that patients
given the label asthma were also included. This allows the
acute physiology score to be used in a fuller model that
includes a variable for the most likely diagnosis of the
airflow obstruction choosing between pure COPD, pure
asthma or a mixture of COPD and asthma.
Cases were excluded if: (1) they were admitted directly
from theatre or from theatre via any other location in the
same hospital, or had a condition requiring surgery specified
as either the primary or secondary reason for admission; (2)
they were readmissions of the same patient within the same
hospital stay; or (3) they were missing the primary outcome
variable of mortality at ultimate discharge from an acute
hospital.
These inclusion and exclusion criteria were chosen to
match as closely as possible the patient group included in
CAOS. Also admissions to units participating in CAOS during
the time period of the study were excluded, as the final
score was to be used in the analysis of CAOS and we wished
the development dataset to remain independent.Selection of physiological variables
Variables were selected, a priori, for inclusion in the full
model if they were available in the Case Mix Programme
Database, and had been shown to have a relationship with
mortality in patients with COPD or asthma in the literature
or in previous analyses of the Case Mix Programme
Database10,11 and could be reliably collected outside ICU.
Qualitative data from the CAOS study were used to identify
variables that were readily available and reliably measured
outside ICU. CAOS study data identified that though the ratio
of PaO2 to FiO2 had shown a significant relationship with
outcome in patients with COPD inside ICU,10 in the pre-ICU
setting the FiO2 was frequently unavailable and so it was
dropped.
The following variables were selected, measured over the
first 24 h following admission to ICU: lowest central
temperature (or lowest non-central temperature +1 1C if
no central temperatures recorded); mean arterial pressure
from the blood pressure with the lowest systolic pressure;
extreme heart rate (furthest from 75min–1); lowest arterial
pH; PaCO2 from the arterial blood gas with the lowest pH;
lowest serum sodium; extreme serum potassium (furthestfrom 4.5mmol l–1); highest serum urea; highest serum
creatinine; highest serum glucose; highest total serum
bilirubin; lowest serum albumin; and lowest white blood
cell count.Statistical methods
The relationship between each continuous physiological
variable and outcome was examined graphically by fitting a
flexible smooth function (generalised additive model with
five degrees of freedom) to the log odds of hospital
mortality.12 These plots were used to divide the continuous
variables into a number of categories. Each categorical
variable was then entered into a logistic regression model
and adjacent categories were combined if they were not
significantly different at the 10% level. Missing physiological
values were assumed to be in the normal range (defined as
the category with the lowest mortality). Imputation
methods were not considered appropriate as the assumption
that data were missing at random was highly likely to be
violated. As a sensitivity analysis, the model development
was repeated assigning missing values to the category with
the highest mortality.
All 13 categorical variables were entered into the full
model. The modelling proceeded in a stepwise manner, with
the least significant variable being removed at each step,
until no variables remained. At each step, the model was
fitted in a randomly selected development sample of two
thirds of all ICUs and evaluated in a validation sample of the
remaining one third of ICUs. The random split into
development and validation samples was repeated 100
times to avoid biasing the results by a single random split
of the data, the model was refitted in each of the 100
development samples and measures of discrimination and
calibration were reported as the median and quartiles over
the 100 validation samples. Discrimination was assessed
with the area under the receiver operating characteristic
(ROC) curve,13 and calibration with the Hosmer–Lemeshow C
statistic.14
During the course of the development work, many more
patients were admitted to units participating in the Case Mix
Programme. This provided the opportunity to validate the
discrimination of the CAPS in an independent validation
sample. The discrimination of the CAPS was compared to
that of the APACHE II acute physiology score,15 APACHE III
acute physiology score,4 and the physiological components
of SAPS II16 in these validation data. Validation was carried
out in all new admissions meeting the inclusion criteria for
this study, and also, for a truly independent sample,
restricted only to admissions to ICUs that had recently
joined the Case Mix Programme and had no data in the
development sample. Admissions were classified as COPD,
asthma or mixed diagnoses based on the primary and
secondary reasons for admission as recorded in the database
and the discrimination of the CAPS was compared between
these three groups.
All analyses were performed in Stata version 8.2
(StataCorp LP, College Station, TX, USA). Logistic regre-
ssion models were fitted with robust standard errors,
clustered by ICU.
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Table 1 Case mix and outcome of admissions included in the development and validation of the COPD and Asthma Physiology
Score.
Development dataset Validation dataset
All admissions Mechanically
ventilated
All admissions Mechanically
ventilated
Admissions, n (%) 8527 6407 (75.1) 7957 5512 (69.3)
Age (years)
Mean (SD) 65.9 (9.7) 65.9 (9.5) 66.5 (10.1) 66.3 (9.9)
Median (IQR) 67 (59–73) 67 (59–73) 67 (59–74) 67 (59–74)
Sex, n (%)
Female 4346 (51.0) 3226 (50.4) 4062 (51.0) 2808 (50.9)
Male 4181 (49.0) 3181 (49.6) 3895 (49.0) 2704 (49.1)
Primary reason for admission, n (%)
Exacerbation of COPD 3023 (35.5) 2329 (36.4) 3221 (40.5) 2317 (42.0)
COPD 2504 (29.4) 1823 (28.5) 2382 (29.9) 1558 (28.3)
Asthma attack 1354 (15.9) 951 (14.8) 1178 (14.8) 795 (14.4)
Emphysema 188 (2.2) 138 (2.2) 115 (1.5) 68 (1.2)
Other related reason 1458 (17.1) 1166 (18.2) 1061 (13.3) 774 (14.0)
APACHE II acute physiology scorey
Mean (SD) 12.9 (5.7) 13.4 (5.7) 13.0 (5.9) 13.7 (6.0)
Median (IQR) 12 (9–16) 12 (9–16) 12 (9–16) 13 (9–17)
AUC (95% CI) 0.650 0.626 0.663 0.642
(0.638–0.662) (0.611–0.640) (0.650–0.676) (0.627–0.657)
APACHE II scorey
Mean (SD) 18.7 (6.5) 19.2 (6.5) 18.7 (6.7) 19.3 (6.8)
Median (IQR) 18 (14–22) 18 (15–23) 18 (14–23) 18 (15–23)
APACHE III acute physiology scorez
Mean (SD) 52.0 (21.6) 53.7 (21.8) 51.1 (22.6) 54.5 (23.3)
Median (IQR) 48 (37–63) 50 (39–65) 47 (36–62) 50 (39–66)
AUC (95% CI) 0.681 0.657 0.703 0.684
(0.669–0.692) (0.643–0.671) (0.691–0.715) (0.669–0.699)
APACHE III scorez
Mean (SD) 64.8 (23.2) 66.6 (23.3) 64.0 (24.1) 67.2 (24.7)
Median (IQR) 62 (49–77) 63 (50–79) 61 (47–76) 63 (50–80)
SAPS II physiological componentsy
Mean (SD) 22.8 (13.7) 26.0 (13.0) 22.1 (13.8) 26.0 (13.3)
Median (IQR) 21 (14–30) 23 (17–32) 19 (13–29) 23 (17–32)
AUC (95% CI) 0.674 0.645 0.689 0.678
(0.662–0.685) (0.631–0.659) (0.676–0.701) (0.664–0.693)
SAPS II
Mean (SD) 40.8 (14.7) 43.9 (14.1) 40.0 (14.9) 43.9 (14.3)
Median (IQR) 39 (31–49) 41 (34–52) 38 (30–48) 41 (34–52)
Ultimate hospital mortality, deaths (%) 3025 (35.5) 2437 (38.0) 2696 (33.9) 2005 (36.4)
COPD, chronic obstructive pulmonary disease; SD, standard deviation; IQR, interquartile range.
Related condition as primary reason for admission (see Methods section), with COPD, exacerbation of COPD, asthma attack or
emphysema as secondary reason.
yExcluding admissions staying less than eight hours in the intensive care unit: 424 in development dataset, 339 in validation dataset.
zExcluding admissions staying less than four hours in the intensive care unit: 199 in development dataset, 133 in validation dataset.
yRemoving weightings for age, past medical history and surgical urgency.
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Patient characteristics
Of 276,731 admissions to 168 adult general critical care
units, 8527 (3.1%) met the inclusion criteria (Table 1). Of
these, 5715 (67.0%) had exacerbation of COPD, COPD or
emphysema as their primary reason for admission, 1354
(15.9%) had asthma attack as the primary reason for
admission, and 1458 (17.1%) had another primary reason
such as pneumonia (see Methods section) with one of the
four primary reasons above (exacerbation of COPD, COPD,
emphysema, or asthma attack) as the secondary reason for
admission. Patients had a mean (SD) age of 65.9 (9.7) and
4181 (49.0%) were male. Mean (SD) acute physiology scores
are given in Table 1. Overall, 3025 (35.5%) patients died
before ultimate discharge from acute hospital. Mechanically
ventilated admissions, which comprised 75% of the devel-
opment sample, were similar in terms of age, sex and
reasons for admission, but had higher severity of illness by
all measures and higher mortality (Table 1).
Admissions recorded as asthma (n ¼ 1364) were generally
younger (mean age 59.5 versus 67.3, Po0.001) and more
likely to be female (65.4% versus 47.9%, Po0.001), with
lower severity of illness (mean APACHE II acute physiology
score 11.8 versus 13.1, Po0.001) and lower hospital
mortality (15.2% versus 39.7%, Po0.001), compared with
admissions recorded as COPD (n ¼ 6992).
By the end of the development work, data had been
received and validated on an additional 217,345 ICU
admissions. Of these, 7957 (3.7%) met the inclusion criteriaTable 2 Stepwise selection of physiological variables models fi
and evaluated in the corresponding validation samples (remainin
Variables dropped Number of
variables
Number of
parameters
AUC
None 13 47 0.720
Potassium 12 45 0.720
Temperature 11 42 0.720
PaCO2 10 40 0.720
Glucose 9 38 0.720
Bilirubin 8 35 0.718
Heart ratez 7 30 0.715
Sodium 6 27 0.713
pH 5 23 0.711
WBC 4 19 0.707
Creatinine 3 16 0.698
Albumin 2 11 0.688
MAP 1 5 0.650
Urea 0 1 0.500
AUC, area under the receiver operating characteristic curve; IQR,
count; MAP, mean arterial pressure.
Hosmer–Lemeshow chi-squared goodness-of-fit statistic on 10
departure from perfect calibration at the 5% significance level. Can
groups.
yPercentage of validation samples showing significant departure fr
zBold type indicates final model.for this study, including 391 admissions to 13 new units that
had no data in the development dataset. The characteristics
of these patients are also described in Table 1.Development of the COPD and Asthma Physiology
Score
Table 2 shows the stepwise selection of variables for the
CAPS. The full model had a median area under the ROC
curve of 0.720 and a median Hosmer–Lemeshow C statistic
of 15.5 in the 100 validation samples. Dropping the least
significant variables in turn initially had no effect on the
discrimination (area under the ROC curve) and improved the
calibration (Hosmer–Lemeshow C statistic) in the validation
samples, suggesting that these variables made no contribu-
tion to the fit of the model. The model with eight variables
was selected for the CAPS (indicated by bold type in Table
2). The eight variables were (in decreasing order of
significance): serum urea, mean arterial blood pressure,
serum albumin, serum creatinine, white blood cell count,
arterial pH, serum sodium, and heart rate. This model had a
median area under the ROC curve of 0.718 and a median
Hosmer–Lemeshow C statistic of 13.4 in the 100 validation
samples, representing a slight improvement in calibration
with very little loss in discrimination compared to the full
model. This compares favourably to the area under the ROC
curves for the acute physiology scores from APACHE II,
APACHE III and the physiological components of SAPS II
(Table 1). Calibration was not perfect, with 23% of valida-
tion samples showing significant departures from perfecttted in 100 random development samples (one third of units)
g two thirds of units).
median (IQR) HL w2 median (IQR) Po0.05y %
(0.713–0.726) 15.5 (10.9–20.0) 32
(0.714–0.727) 14.6 (9.7–20.1) 32
(0.714–0.726) 13.7 (9.7–20.1) 34
(0.714–0.725) 13.8 (9.3–19.0) 27
(0.714–0.725) 13.1 (9.1–20.6) 29
(0.713–0.724) 13.4 (9.7–17.8) 23
(0.710–0.722) 12.7 (9.4–17.2) 15
(0.709–0.720) 12.1 (8.3–15.5) 19
(0.706–0.718) 11.4 (8.4–15.7) 15
(0.702–0.715) 11.9 (7.6–16.7) 19
(0.693–0.705) 11.3 (7.5–16.0) 15
(0.680–0.695) 15.4 (9.4–22.4) 44
(0.640–0.655) – –
– –
interquartile range; HL, Hosmer–Lemeshow; WBC, white blood
degrees of freedom. Values over 18.30 indicate a significant
not be calculated when categories define fewer than 10 distinct
om perfect calibration at the 5% level.
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Table 3 The COPD and Asthma Physiology Score.
Heart rate min–1 o80 80–109 110–129 130–149 150–169 X170
Score 3 0 2 3 5 7
MAP mmHg o40 40–49 50–59 60–69 70–89 90–99 X100
Score 19 12 9 6 3 0 4
pH pH o7.00 7.00–7.09 7.10–7.19 7.20–7.24 X7.25
Score 9 6 3 1 0
Sodium mmol l–1 o130 130–134 135–144 X145
Score 6 2 0 2
Urea mmol l–1 o2.5 2.5–6.7 6.8–11.9 12.0–17.9 X18.0
Score 0 8 16 22 24
Creatinine mmol l–1 o150 150–199 X200
Score 0 5 8
Albumin g l–1 o15 15–19.9 20–24.9 25–29.9 30–34.9 X35
Score 20 14 8 6 4 0
WBC  109 l–1 o4 4–14.9 15–19.9 20–24.9 X25
Score 7 0 1 4 7
MAP, mean arterial pressure; WBC, white blood count.
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Figure 1 Distribution of the COPD and Asthma Physiology
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Figure 2 Relationship between the COPD and Asthma Physio-
logy Score and mortality.
COPD and Asthma Physiology Score 1999calibration at the 5% significance level. This is to be
expected, firstly because many known prognostic factors
for COPD were not included in the model as we were
only evaluating physiological derangement, and secondly
because such a large sample size has the power to detect
even very small variations from perfect calibration as being
significant.
Table 3 shows the eight physiological variables that were
retained in the final score and the points ascribed to the
ranges of values of these variables that go to make up the
CAPS. In general, it can be seen that the further a
physiological parameter strays from normal the greater
the score it attracts, indicating a higher risk of mortality.
The score ranges from zero to a maximum score of 100.
Figure 1 shows the distribution of the CAPS amongst the
8527 admissions in the development dataset. The median(interquartile range) score was 34 (27–43), with 8.1% of
admissions having a score below 20, 58.9% between 20 and
39, 29.1% between 40 and 59, and only 3.9% with a score of
60 or more.
Figure 2 shows the relationship between the CAPS and
mortality in the development dataset, and Table 4 shows the
odds ratios for hospital mortality for each component of the
CAPS both unadjusted and adjusted for all other CAPS
components.
Physiological values were missing for between 1% and 2%
(routine measurements: heart rate, mean arterial blood
pressure, temperature), 4–6% (common additional tests:
arterial blood gases, sodium, potassium, creatinine, white
blood cell count) and 14–32% (less common tests: urea,
glucose, albumin, bilirubin). The sensitivity analysis, allo-
cating missing values to the category with the highest
ARTICLE IN PRESS
Table 4 Odds ratios for hospital mortality associated with the components of the COPD and Asthma Physiology Score.
Variable Category Odds ratio (95% confidence interval)
Unadjusted Adjusted
Heart rate, min–1 o80 1.53 (1.22–1.92) 1.24 (0.97–1.59)
80–109 1.00 1.00
110–129 1.11 (0.97–1.26) 1.13 (0.99–1.30)
130–149 1.23 (1.07–1.40) 1.21 (1.05–1.41)
150–169 1.53 (1.29–1.83) 1.44 (1.19–1.75)
X170 2.52 (2.00–3.18) 1.99 (1.54–2.56)
MAP, mmHg o40 7.15 (5.12–9.99) 3.90 (2.73–5.56)
40–49 4.14 (3.07–5.58) 2.61 (1.90–3.59)
50–59 2.86 (2.16–3.78) 1.96 (1.46–2.64)
60–69 1.99 (1.51–2.63) 1.58 (1.18–2.11)
70–89 1.41 (1.07–1.86) 1.29 (0.96–1.72)
90–99 1.00 1.00
X100 1.58 (1.02–2.44) 1.30 (0.83–2.06)
pH o7.00 3.10 (2.31–4.16) 1.95 (1.40–2.71)
7.00–7.09 2.20 (1.87–2.60) 1.49 (1.24–1.79)
7.10–7.19 1.71 (1.53–1.90) 1.26 (1.11–1.42)
7.20–7.24 1.22 (1.07–1.39) 1.05 (0.91–1.22)
X7.25 1.00 1.00
Sodium, mmol l–1 o130 1.61 (1.39–2.20) 1.50 (1.28–1.77)
130–134 1.26 (1.12–1.41) 1.13 (1.00–1.28)
135–144 1.00 1.00
X145 1.87 (1.59–2.20) 1.20 (0.99–1.46)
Urea, mmol l–1 o2.5 1.00 1.00
2.5–6.7 1.92 (0.95–3.88) 1.81 (0.88–3.72)
6.8–11.9 4.23 (2.10–8.49) 3.13 (1.53–6.39)
12.0–17.9 7.03 (3.48–14.21) 4.61 (2.24–9.49)
X18.0 11.42 (5.64–23.15) 5.40 (2.60–11.22)
Creatinine, mmol l–1 o150 1.00 1.00
150–199 2.60 (2.30–2.93) 1.51 (1.30–1.75)
X200 4.50 (3.86–5.25) 1.89 (1.56–2.29)
Albumin, g l–1 o15.0 9.36 (6.56–13.36) 4.37 (2.97–6.42)
15–19.9 4.53 (3.67–5.60) 2.70 (2.15–3.41)
20–24.9 2.50 (2.09–2.99) 1.75 (1.44–2.13)
25–29.9 2.10 (1.81–2.43) 1.57 (1.34–1.85)
30–34.9 1.53 (1.28–1.82) 1.33 (1.10–1.60)
X35 1.00 1.00
WBC  109 l–1 o4 2.82 (1.93–4.12) 1.67 (1.09–2.54)
4–14.9 1.00 1.00
15–19.9 1.15 (1.02–1.30) 1.07 (0.93–1.22)
20–24.9 1.75 (1.53–1.99) 1.38 (1.18–1.62)
X25 2.29 (1.85–2.85) 1.69 (1.33–2.15)
MAP, mean arterial pressure; WBC, white blood count.
Adjusted for all other parameters in the table.
M.J. Wildman et al.2000mortality, resulted in no change in the eight variables
selected for the model and little difference to the overall fit
of the model; however, the weightings produced by this
model were inappropriate as high risk categories (containing
missing values) were allocated low weights.Validation of the COPD and Asthma Physiology Score
The area under the ROC curve for the CAPS was 0.720 (95%
confidence interval 0.708–0.732) in the independent valida-
tion data. This was significantly higher than for the APACHE II
ARTICLE IN PRESS
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Figure 3 Receiver operating characteristic curves for the
COPD and Asthma Physiology Score in admissions with COPD,
asthma and mixed diagnoses in the independent validation
data.
COPD and Asthma Physiology Score 2001acute physiology score (AUC ¼ 0.663, Po0.0001), the
APACHE III acute physiology score (AUC ¼ 0.703, P ¼ 0.004)
and the physiological components of SAPS II (AUC ¼ 0.689,
Po0.0001). The area under the ROC curve was 0.751
(0.703–0.800) when restricted to new units only. Using
coefficients calculated from the development dataset, the
Hosmer–Lemeshow C statistic for calibration in the valida-
tion data was 10.7 (P ¼ 0.38), and 12.2 (P ¼ 0.27) when
restricted to new units only.
Figure 3 shows a comparison of the ROC curves for
admissions with COPD (n ¼ 6646), asthma (n ¼ 1121) and
mixed diagnoses (n ¼ 100) in the independent validation
data. Discrimination of the CAPS was better for admissions
with asthma than COPD (P ¼ 0.036), the sample with mixed
diagnoses being too small to make any meaningful compar-
isons.Discussion
This study has developed a disease-specific acute physiology
score for use in patients with acute exacerbations
of obstructive airways disease. The study is a response
to the problem that risk adjustment models taking
account of acute physiology will typically require very
large numbers of patients, and to date there have been
no prospective studies of COPD patients with acute
exacerbations that have had adequate power to weight
the prognostic significance of acute physiological
variables.
The CAPS uses eight physiological variables classified into
41 levels with a minimum of 340 deaths required to have the
power to weight the score without a material risk of
overfitting.5 ICUs possess the infrastructure to collect case
mix data on admissions and allowed this study to use datafrom 8527 admissions and 3025 deaths to establish the
weights that should be given to the physiological variables.
Collecting data outside ICU is far more difficult and even the
$26 million SUPPORT study which is the largest prospective
study to develop a prognostic model for hospitalized COPD
patients only recruited 1016 COPD patients with 250 deaths
by 180 days.3 Despite the CAOS study recruiting from 95
hospitals for 18 months, only 651 patients without treat-
ment limitation were identified prior to ICU admission with
220 deaths by 180 days.
The strengths of the CAPS are that the variables used
were identified from the literature as having a potential to
predict COPD survival and were also found in the CAOS study
to be practical to collect in the acute setting. In addition,
the CAPS has the theoretical advantage over generic scores
such as APACHE III, which are developed using all diagnostic
groups, of being disease-specific: specifically developed on
patients admitted to ICU with exacerbations of obstructive
airways disease.
The discrimination of the CAPS for predicting hospital
mortality significantly exceeded that of the acute physiology
scores from APACHE II and APACHE III and the physiological
components of SAPS II in the validation data, despite being a
simpler model, based on observations of only eight
physiological parameters compared with 12, 16 and 12
parameters for APACHE II, APACHE III and SAPS II, respec-
tively.
The use of outcome models to support decision-making
is seen by some commentators to be problematic in that
such models will produce outcome predictions that describe
the average outcomes for similar patients but the ultimate
outcome for the individual patient remains unknown.
It should be remembered that such scores also have
utility in case mix adjustment and audit studies that
look at cohort outcomes. When it comes to individual
patients, if prognostication is to have any role in decision-
making then a prognostic estimate will need to come from
somewhere. In the SUPPORT study, when clinicians’
outcome predictions for COPD patients were compared to
the SUPPORT model clinicians’ predictions had a lower
ROC, were less well calibrated and were pessimistic.3 It
could be argued that if clinicians’ estimates are poorly
calibrated then using a score alongside clinical
judgement may well improve prognostic estimates, and
the SUPPORT study confirmed this. It might also be argued
that in the face of uncertainty all patients should be
admitted, but simulation studies in the UK suggest that
patients are refused intensive care on the basis of prognosis
and that when clinicians make judgements about identical
patients disagreements occur with non-admitters forming
markedly more pessimistic prognoses.2 In the light of this,
we would consider objective prognostic estimates, with
acknowledged uncertainty, to be a useful adjunct to clinical
judgement.
In conclusion, the CAPS can be used to estimate the
prognostic impact of the physiological derangements
accompanying an acute exacerbation of obstructive airways
disease and has the potential for even greater predictive
performance when used in combination with measures
of a patient’s functional reserve. Further validation of this
score outside of ICU and outside of the UK setting is
recommended.
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